TY  - GEN
AU  - Posadas,Edwin M
AU  - Limvorasak,Suwicha
AU  - Figlin,Robert A
TI  - Third-Line Treatment Options for Kidney Cancer
SN  - 0890-9091
PY  - 2017///0606
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Drug Costs
KW  - Drug Substitution
KW  - Genetic Predisposition to Disease
KW  - Genetic Testing
KW  - methods
KW  - Humans
KW  - Kidney Neoplasms
KW  - Patient Selection
KW  - Phenotype
KW  - Precision Medicine
KW  - Predictive Value of Tests
KW  - Time Factors
KW  - Treatment Failure
N1  - Publication Type: Journal Article
ER  -